Brief: Bergenbio Q3 Operating Loss NOK 27.2 Mln

Oncoinvent ASA

13/11/2024 08:21

Nov 13 (Reuters) - BerGenBio ASA  BGBIO.OL :
    * SAID ON WEDNESDAY Q3 OPERATING REVENUES NOK 0.0 MLN 
    * Q3 OPERATING LOSS NOK 27.2 MLN 
    * CONTINUES WORK TOWARDS UPCOMING MILESTONES FOCUSED ON
CLINICAL
DEVELOPMENT OF BEMCENTINIB IN NSCLC STK11M PATIENTS


        
 Source text for Workspace:  urn:newsml:reuters.com:*:nWkr6dVL63
 Further company coverage:  BGBIO.OL  

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))